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Differentiated Thyroid Carcinoma of Children and Adolescents: 
27-Year Experience in the Yonsei University Health System
Thyroid carcinomas are uncommon in childhood and adolescence. The aim of this study 
was to analyze clinical features and clinical outcomes of thyroid cancer in the pediatric 
population treated in the Yonsei University Health System. From September 1982 to June 
2009, 90 patients (75 females, 15 males; female:male ratio of 5:1) with differentiated 
thyroid carcinoma were identified in our institute. The mean age at diagnosis was 15.8 yr 
old (range 4.8-19.9 yr). Cervical masses were most common clinical manifestations at 
diagnosis in 65 patients (72.2%). Forty-two patients underwent less than total 
thyroidectomy and 18 patients underwent total thyroidectomy. Thirty patients (33.3%) 
had lateral neck lymph node metastasis and seven patients (7.8%) had lung metastasis at 
the time of surgery. Among the 90 patients, recurrence occurred in 14 patients (15.5%). 
Mean follow-up period for patients with differentiated thyroid carcinoma was 81.6 
months (13-324 months). No patients died of differentiated thyroid carcinoma. Patients 
with differentiated thyroid carcinoma who were < 20-yr-of-age were present with 
aggressive local disease and a high frequency of lymph node and distant metastasis. It is 
recommended that pediatric thyroid cancer should be managed mostly using proper 
surgical approach with thyroidectomy and lymph node dissection when indicated.
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Oncology & Hematology
INTRODUCTION
Primary thyroid carcinoma is uncommon in childhood and ad-
olescence constituting 0%-3% of all pediatric malignancies (1-
4). Sporadic differentiated thyroid cancers (papillary and mixed 
papillary-follicular) are the most common endocrine malig-
nancies in children, and a female preponderance is most pro-
nounced in postpubertal children (5). Follicular thyroid carci-
noma is less common than papillary thyroid carcinoma in pe-
diatric patients. Also, anaplastic and undifferentiated thyroid 
carcinomas are extremely rare. In the pediatric age group, spo-
radic medullary thyroid carcinoma (MTC) is uncommon and 
more frequently presents as a manifestation of multiple endo-
crine neoplasia (MEN) type IIA and IIB (6). 
 Differentiated thyroid carcinoma in pediatric patients differs 
from thyroid carcinoma in adults in clinical manifestations and 
clinical outcomes. Despite an overall survival rate exceeding 
95%, pediatric thyroid carcinoma is often more advanced with 
lymph node metastasis and pulmonary metastasis at diagnosis 
and local recurrence is more frequent after thyroid operation 
than in adults (7-9). However, even though the stage is advanced, 
the prognosis is excellent for pediatric patients, with a low mor-
tality rate.
 Some studies have attempted to evaluate about the prognos-
tic factor in pediatric thyroid cancer for the proper treatment 
but the prognostic factors have been evaluated poorly (9). Be-
cause of a lack of randomized studies, the optimal initial surgi-
cal treatment is controversial, and the impact of the initial sur-
gery on the outcome remains unclear (3). Total thyroidectomy 
with lymph node dissection reduces the recurrence rate (10, 
11), but carries a high risk of permanent hypoparathyroidism 
and vocal cord injury. Some investigators have advocated less 
radical surgery in pediatric patients (11, 12).
 This study was analyzed the clinical features and clinical out-
comes of thyroid cancer in the pediatric population at Yonsei 
University Health Service for 27 yr and discuss about the proper 
management of the differentiated thyroid cancer in pediatric 
population.
MATERIALS AND METHODS
Between 1982 and 2009, 94 pediatric patients underwent thy-
roid surgery at Yonsei University Health System for primary 
thyroid carcinoma (differentiated thyroid carcinoma, 90 pa-
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tients; medullary thyroid carcinoma, 4 patients; papillary thy-
roid carcinoma, 78 patients; follicular thyroid carcinoma, 12 
patients). Patients with medullary thyroid carcinoma were ex-
cluded. Pediatric age is defined as < 20-yr. Retrospectively eval-
uated medical data was evaluated sex, age at the time of surgery, 
clinico-pathologic characteristics, TNM stage, type of surgery, 
postoperative complications, recurrences and survival rate. Cli-
nico-pathologic characteristics included chief complaint at di-
agnosis, tumor size, extrathyroidal extension, multifocality, bi-
laterality, family history, thyroiditis and lymph node involve-
ment. Pathologic staging adopted the 7th American Joint Com-
mittee on Cancer (AJCC) at the time of initial diagnosis.  
 At our institution, thyroid resection consisted of total thyroid-
ectomy and less than total thyroidectomy. The definition of “less 
than total thyroidectomy” is specified by unilateral thyroid lo-
bectomy, ipsilateral total and contralateral partial thyroidecto-
my and ipsilateral total and contralateral subtotal thyroidecto-
my. The choice of surgical extension was based on ATA guide-
lines (13). During thyroid resection, only central compartment 
lymph nodes (CCLN) located in the ipsilateral site of the pri-
mary tumor were dissected prophylatically. The CCLN or level 
VI included the pretracheal, paratracheal, prelaryngeal, peri-
thyroidal nodes and lymph nodes located along the recurrent 
laryngeal nerve. The central compartment was delimited supe-
riorly by the hyoid bone, inferiorly by the substernal notch, lat-
erally by the median portion of the carotid sheath and dorsally 
by the prevertebral fascia. Recurrent laryngeal nerves and para-
thyroid glands were identified and preserved in all cases. The 
procedures were performed by the same surgical team. If pa-
tients had evidence of lateral lymph node metastasis in preop-
erative evaluation, modified radical neck dissection was per-
formed. Radioactive iodine remnant ablation was performed 
within 6 weeks after surgery. Indication for radioiodine ablation 
in this cohort of patients was based on ATA guidelines (13). A 
131I whole body scan was taken on day 2 following radioactive 
iodine (RI) therapy. Dose of radioactive iodine for children was 
calculated based on the patient’s body weight (0.5-1.5 mCi/kg). 
All patients received thyroid-stimulating hormone suppression 
treatment with levothyroxine according to ATA guidelines (13). 
The recurrence after surgery was assessed by regular follow-up 
every 3 or 6 months. All patients in whom recurrence was sus-
pected were confirmed using cytology and/or histology. Follow- 
up data was obtained by medical chart retrospectively until De-
cember 2011. This retrospective study was approved by the In-
stitutional Review Board of Yonsei University Severance Hospital.
Ethics statement
This study was approved by the institutional review board of 
Severance Hospital, Yonsei University College of Medicine in 
Seoul, Korea (IRB number: 4-2010-0476). Informed consent 
was waived by the board.
RESULTS
Population
Ninety patients (75 females, 15 males; female:male ration, 5:1; 
78 patients with papillary carcinoma, 12 patients with follicular 
carcinoma) underwent surgery for differentiated thyroid carci-
noma in our institute. The mean age at diagnosis was 15.8 yr 
(females, 16.3 yr; males, 13.3 yr; range, 4.3-19.9 yr). 
Clinical presentation
A neck mass was the most common chief complaint. Sixty five 
patients (72.2%) had a neck mass: in 50 patients, the mass was 
an anterior neck mass and in 15 patients it was a lateral neck 
mass. Other initial causes were incidentalomas in 18 cases (in-
cluding patients who were followed-up due to thyroid disease 
and screening test), hoarseness in two cases and neck pain in 
one case. One patient underwent Sistrunk operation due to 
thyroglossal duct cyst, and the final diagnosis was confirmed as 
papillary thyroid carcinoma. One patient was diagnosed as thy-
roid carcinoma with lung metastasis during mumps treatment. 
In one patient, the lung metastasis was discovered during the 
pneumothorax operation and a wedge resection of the lung 
was performed, with papillary thyroid carcinoma subsequently 
confirmed. One patient had a previous history of exposure to 
ionizing radiation because of rhabdomyosarcoma in the left 
mandible. That patient had multiple malignancies which were 
chondrosarcoma in the left clavicle and osteosarcoma in the 
left knee. The patient treated chemotherapy and radiation ther-
apy (Table 1). At the time of surgery, 60 patients had localized 
disease in central neck and 30 patients had lateral neck node 
metastasis. Seven patients had pulmonary metastasis at the time 
of surgery and all patients with pulmonary metastasis present-
ed lateral neck node metastasis at the time of surgery.
Table 1. Clinical manifestations at initial diagnosis in pediatric thyroid cancer patients
Parameters  No. (n = 90) %
Mean age (yr)
< 5 yr
5 ≤ age < 15
15 ≤ age < 20
   15.8
  1
23
66
(4.3-19.9)
  1.1
25.6
73.3
Sex
Male/Female 15/75 1/5
Duration of symptoms 8.3 month
Chief complaint
 Neck mass
Anterior
Lateral
Incidentaloma
Hoarseness
Thygolssal duct cyst
Neck pain
Mumps
Pneumothorax
Rabdomyosarcoma
65
50
15
18
  2
  1
  1
  1
  1
  1
72.2
20
2.2
1.1
1.1
1.1
1.1
1.1
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Surgery
Surgical treatment consisted of less than total thyroidectomy 
(42 patients, 46.7%), total thyroidectomy (18 patients, 20%) and 
total thyroidectomy with modified radical neck node dissection 
(30 patients, 33.3%). Thirty patients had lateral neck node me-
tastasis, 16 patients underwent total thyroidectomy with central 
compartment node dissection (CCND) and unilateral modified 
radical neck dissection (MRND) and 14 patients underwent to-
tal thyroidectomy with CCND and bilateral MRND (Table 2). 
Pathologic characteristics
Mean tumor size was 23.6 mm (range 2-60 mm). Microcarcino-
ma was present in 18 cases (20%) and six patients (6/18, 33.3%) 
had lateral neck node metastasis with microcarcinoma. Seven-
teen patients (18.9%) had bilaterality and 26 patients (28.9%) 
had multifocality. Extrathyroidal extension was evident in 51 
cases (56.7%). Sixteen patients had diffuse thyroiditis (17.8%). 
Fifty four patients (60%) displayed central lymph node metas-
tasis and 30 patients (33.3%) displayed lateral neck node me-
tastasis. In the 30 patients without central lymph node metasta-
sis, three patients (10%) displayed lateral neck node metastasis. 
Two patients had recurrent laryngeal nerve invasion, during 
the operation the nerve was dissected for the treatment (Table 
3). In addition, concerning the TNM stage, stage I and stage II 
comprised 83 cases (92.2%) and seven cases (7.8%), respectively.
Radioactive iodine (RI) therapy
Postoperative RI was administered to 41 of 48 patients (85.4%) 
presenting with lung metastasis at initial diagnosis. Mean age 
of the 41 patients (nine males, 32 females, 1:3.6 ratio) was 15.6 
yr (range 5-19.9 yr). The tumor size was 23.5 ± 12.6 mm. The RI 
dose ranged from 30 mCi to 750 mCi in initial non-pulmonary 
metastasis patients. In patients with initial pulmonary metasta-
sis who received RI therapy, the dose ranged from 150-1,050 
mCi (1-5 times). One patient received external beam radiation 
therapy.
Recurrence
The mean follow-up duration was 81.6 months (range 13-324 
months) and no patients died of thyroid carcinoma. During the 
follow-up period, recurrence occurred in 14 patients (15.6%). 
Recurrence was in the lateral neck (n = 6, 42.9%), operation 
bed (n = 4, 28.6%), contra-lateral thyroid gland and lateral neck 
(n = 2, 14.3%), remaining contra-lateral thyroid gland (n = 1, 
7.1%) and operation bed and lateral neck (n = 1, 7.1%) (Table 4). 
These patients were treated with appropriate therapy, such as 
completion total thyroidectomy, MRND and RI treatment. The 
recurrence-free survival rate was 88.9% at 5 yr and 78.9% at 10 
yr from initial operation (Fig. 1). Two patients died with a non-
specific disease cause. One patient died with intracranial hem-
orrhage due to leukemia. The other patient with disseminated 
rhbdomyosarcoma died with multi-organ failure. No patients 
died of differentiated thyroid carcinoma. After the initial opera-
Table 2. Summary of operation methods
Operation method No. (n = 90)
Less than total 
Lobectomy and isthmectomy
Ipsilateral total and controlateral partial
Ipsilateral total and controlateral subtotal
42
30
  8
  4
Total thyroidectomy 18
Total and ipsilateral MRND 16
Total and bilateral MRND 14
Table 3. Pathologic characteristics in pediatric thyroid carcinoma patients
Findings No. (%)
Mean tumor size (mm) 23.6 mm
Microcarcinoma 18 (20)
Thyroiditis 16 (17.8)
Bilaterality 17 (18.9)
Multifocality 26 (28.9)
Extrathyroidal extension 51 (56.7)
Central lymph node metastasis 54 (60)
Lateral neck node metastasis 30 (33.3)
Nerve invasion 2 (2.2)
Skip metastasis 3/30 (10)
Table 4. Recurrence site after initial operation
Site No. (n = 14)
Lateral neck 6
Operation bed 4
Contra-lateral thyroid and lateral neck 2
Operation bed and lateral neck 1
Contra-lateral thyroid 1
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Fig. 1. Recurrence free survival rate in pediatric patients with differentiated thyroid 
carcinoma. 
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tion, five of the 14 patients with recurrence had lung metastasis 
and were treated with RI and thyroid stimulating hormone (TSH) 
suppression. 
Papillary thyroid microcarcinoma
Eighteen patients (20%) had a cancer with a tumor size ≤ 10 
mm. Mean age was 16.9 yr (range, 6-19 yr) and the male:female 
ratio was 1:17. Nine patients were diagnosed incidentally in the 
follow-up period with thyroid disease (goiter, hypothyroidism 
and hyperthyroidism) and screening test, six patients had an 
anterior neck mass and three patients had a lateral neck mass. 
Mean tumor size was 6.4 ± 2.6 mm (range, 3-10 mm). One pa-
tient had bilaterality and four patients had multifocality. Extra-
thyroidal extension occurred in eight cases. Six patients had 
diffuse thyroiditis. Central lymph node metastasis was evident 
in 12 of 18 patients (66.7%). Six of 18 patients (33.3%) with lateral 
neck node metastasis received total thyroidectomy with central 
lymph node dissection and ipsilateral modified radical neck 
dissection. After the initial surgery, only one patient experienced 
recurrent thyroid cancer in the operation bed.  
Lung metastasis
At the time of surgery, lung metastasis was detected in seven 
cases (7.8%) of papillary thyroid carcinoma. After surgical exci-
sion (total thyroidectomy with CCND with/without MRND), 
radioactive iodine and TSH suppression therapy were added, 
considering the body weight of patient. External radiation ther-
apy was administered to one of seven patients with pulmonary 
metastasis.
Postoperative complication
Twenty four patients (26.7%) had postoperative complication 
with hypocalcemia (transient in 19 patients and permanent in 
5 patients). No incidental recurrent laryngeal nerve injury was 
noted, but two cases were resected intentionally due to the en-
casement of the tumor to the recurrent laryngeal nerve. Post-
operative bleeding and infection were not noted.
Comparisons of clinicopathologic characteristics among 
different age groups 
After grouping patients with thyroid carcinoma into two groups 
according to the age at diagnosis (children, age < 15 yr; adoles-
cents, 15 ≤  age ≤ 20 yr), their clinical and pathological charac-
teristics were compared (Table 5). When the clinicopathologic 
characteristics of patients with thyroid carcinoma were com-
pared according to age group, there were no statistically signifi-
cant differences among the age groups in terms of pathologic 
diagnosis proportion of papillary thyroid carcinoma, presence 
of thyroiditis, central lymph node metastasis rate and distant 
metastasis rate. However, there were significant differences be-
tween the two groups in terms of gender ratio, tumor size, oper-
ation method, extrathyroidal extension, bilaterality, multifocal-
ity and lateral lymph node metastasis rate. The male:female ra-
tio was 1:1.18 and 1:15.5 in the < 15-yr-old group and ≥ 15-yr-
old group, respectively. Although both groups had a higher 
proportion of females, the proportion of males was significantly 
higher in the younger age group (P = 0.001). As well, this young-
er age group had more aggressive factors such as high extrathy-
roidal extension, bilaterality, multifocality and larger tumor size 
Table 5. Comparison with clinicopathologic characteristics among the different age groups
Characteristics
Age < 15 yr
n = 24 (%)
15 ≤ Age ≤ 20
n = 66 (%)
P value
Age at operation (yr) 10.83 ± 3.06 17.64 ± 1.28 0.001 
Gender Male
Female
11 (45.8)
13 (54.2)
4 (6.1)
62 (93.9)
0.001 
Maximum tumor size (mm) 29.96 ± 12.63 21.25 ± 13.58 0.007 
Pathology Papillary thyroid carcinoma
Follicular thyroid carcinoma
20 (83.3)
4 (16.7)
58 (87.9)
8 (12.1)
0.726 
Operation method Less than total
TT with CCND
MRND, unilateral
MRND, bilateral 
7 (29.2)
2 (8.3)
6 (25.0)
9 (37.5)
35 (53.0)
16 (24.2)
10 (15.2)
5 (7.6)
0.006 
Extrathyroidal extension Present 21 (87.5) 30 (45.5) 0.001 
Bilaterality Present 11 (45.8) 6 (9.1) 0.001 
Multifocality Present 12 (50.0) 14 (21.2) 0.016 
Thyroiditis Present 4 (16.7) 12 (18.2) 1.000 
Central lymph node metastasis Present 17 (70.8) 37 (56.1) 0.233 
Lateral neck node metastasis Present 15 (62.5) 15 (22.7) 0.001 
Distant metastasis Present 4 (16.7) 3 (4.5) 0.079 
TNM stage I
II
20 (83.3)
4 (16.7)
63 (95.5)
3 (4.5)
0.079 
Recurrence Present 6 (25.0) 8 (12.1) 0.187 
Follow up duration (Months) 81.16 ± 57.84 82.27 ± 70.04 0.945 
TT, Total thyroidectomy; CCND, Central compartment neck dissection; MRND, Modified radical neck dissection.
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(P = 0.001, P = 0.001, P = 0.016, and P = 0.007, respectively). Al-
though those < 15-yr-old group had more aggressive factors, 
there were no significant differences between two groups in 
terms of the recurrence free survival rate (P = 0.258, Fig. 2) and 
recurrence rate (P = 0.187).
DISCUSSION
Thyroid carcinoma in the pediatric population is a rare type of 
malignancy that displays different tumor characteristics com-
pared with adult thyroid cancers. Pediatric thyroid cancer is ag-
gressive, has a higher prevalence of lymph node metastasis and 
pulmonary metastasis at the time of initial diagnosis and oc-
curs more frequently after surgery (7-9, 14). However, the prog-
nosis is excellent. The reason for this discrepancy is unclear, but 
some hypotheses for pediatric thyroid cancer have been sug-
gested. Zimmerman et al. reported that nondiploid DNA amount 
was 10% in pediatric thyroid cancer and 20% in adult thyroid 
cancer. The authors suggested that a low incidence of nondip-
loid DNA was related to the good prognosis in pediatric thyroid 
cancer (8). The other possibility is that the thyroid gland during 
infancy and childhood is more susceptible to carcinogenic 
stimuli. TSH may play a more prominent role as a promoting 
factor in younger patients. Therefore, postoperative TSH sup-
pression with thyroid hormone replacement is more effective 
and the dedifferentiation from well differentiated to poorly dif-
ferentiated carcinoma does not often occur in pediatric thyroid 
carcinoma (9, 15). 
 Some molecular-based studies were performed. But, the bio-
logic basis for such a difference is essentially unknown. Several 
studies have reported that BRAF V600E mutations are more 
common in older patients with aggressive papillary thyroid can-
cer (16), and that RET/PTC1 rearrangement are more common 
in children with papillary thyroid cancer (17, 18). 
 In our study, the incidence of thyroid carcinoma increased 
with age ( < 5 yr, n = 1; 5-15 yr, n = 23; 15-20 yr, n = 66), with the 
oldest age group comprising 73.3% of the total patients. Our 
study shows high incidence of lymph node metastasis (60%). 
The incidence of lymph node metastasis in the pediatric group 
was similar to adults, in whom the prevalence of the subclinical 
central lymph node metastasis has been reported up to 80% in 
adult thyroid cancer (19, 20). 
 Fourteen patients (15.6% of total) recurred in our study. This 
rate of recurrence was substantially lower previous values of 35-
40% (1, 4, 7, 8). Among the cases of differentiated pediatric thy-
roid cancer, 12 patients with follicular thyroid cancer did not re-
cur. In our study, the incidence of central lymph node metasta-
sis was high but the recurrence rate was low. This low incidence 
of recurrence rate supports the use of our institutional policy - 
that prophylactic central lymph node dissection is needed in 
thyroid cancer patients even if the tumor size is small - for both 
pediatric and adult patients. 
 Concerning the relationship of multiple factors, which some 
studies argued predictive factors for recurrence in pediatric thy-
roid cancer, our study did not reveal any relationship between 
recurrence and factors such as age, gender, extracapsular inva-
sion, bilaterality, multifocality, thyroiditis, central lymph node 
metastasis, lateral neck node metastasis, type of operation and 
RI therapy. The possible relationship between patient age and 
recurrence has been studied. Some studies reported higher re-
currence rate for children < 10 yr or < 15 yr (4, 7), but others 
did not confirmed this relationship (21).
 The most impressive finding in the present study is that 18 
patients (18/90, 20%) had papillary thyroid microcarcinoma 
(PTMC). PTMC patients comprise 3.1%-18.2% of those with lym-
ph node metastasis and up to 20% of locoregional recurrences, 
although PTMC is usually indolent and curable with surgical 
thyroidectomy often followed by RI therapy in adult thyroid 
cancer (22-24). However, this study showed a higher incidence 
of central lymph node metastasis (12/18, 66.7%) and lateral 
neck node metastasis (6/18, 33.3%). On the other hand, the re-
currence rate of PTMC patients was low (1/18, 5.6%) after initial 
surgery. PTMC patients did not have lung metastasis and re-
currence even though the patients had lateral neck node me-
tastasis. Among six patients with lateral neck node metastasis, 
one case had skip metastasis, with in no central lymph node 
metastasis with lateral neck node metastasis only. Even though 
the primary cancer size was < 1 cm, the chief complaint was 
palpable mass in the neck (5/6, 83.3%) due to the metastatic 
lymph node in the PTMC patients with lateral neck node me-
tastasis. Until now, the studies about pediatric PTMC have been 
rare. Even the present findings are limited by small number of 
patients and short follow-up period. The present data is insuffi-
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Fig. 2. Comparison with recurrence free survival rate among the different age groups.
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cient to make any conclusion in pediatric PTMC. However we 
can conclude that PTMC in pediatric thyroid cancer is not rare 
and has a high incidence of lymph node metastasis, low inci-
dence of recurrence and that pediatric PTMC is possible me-
tastasis to the lateral neck like adult.
 The treatment of the pediatric thyroid cancer remains con-
tentious. Because of the low incidence of pediatric thyroid can-
cer, a prospective trial is difficult to perform. Some studies sup-
ported the idea that a total thyroidectomy with central lymph 
node dissection by experts is safe and does not increase the 
possibility of serious complications (25). On the other hand, a 
conservative stepwise approach has been recommended to 
prevent surgical complications and to avoid over-surgery for 
non-advanced disease in pediatric thyroid cancer patients (8). 
Our results suggest that, even though the prognosis is excellent 
in pediatric thyroid cancer, proper surgery including lymph 
node dissection is needed to reduce the recurrence after sur-
gery. Of course, TSH suppression treatment is required. 131I dose 
administered is adjusted by weight and by additional safety fac-
tors dependent on age if it is indicated. 
 In conclusion, our study shows that pediatric thyroid cancer 
has aggressive features at initial diagnosis but that the recur-
rence rate and mortality rate are low. The most common reason 
for hospital care in pediatric patients with papillary thyroid car-
cinoma was a palpable neck mass. In a pediatric population, a 
neck mass should be considered an indication of thyroid can-
cer. If pediatric thyroid cancer is diagnosed, further work-up 
should be performed due to the possibility of lateral neck node 
metastasis and distant metastasis. Pediatric thyroid cancer can 
be managed mainly using the proper surgical approach with 
total thyroidectomy and lymph node dissection when indicated. 
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